Mirion Technologies Reports Record Financial Performance for 2024
Mirion Technologies, Inc. (NYSE: MIR), a leading global provider of radiation safety and detection solutions, recently released its impressive financial results for the fourth quarter and full year of 2024. With revenues climbing steadily, the company has positioned itself as a cornerstone in the medical, nuclear, defense, and research sectors.
Outstanding Fourth Quarter and Yearly Performance
For the year ending December 31, 2024, Mirion demonstrated exceptional performance across all financial metrics, revealing record-high revenues, adjusted EBITDA, and adjusted earnings per share (EPS). CEO Thomas Logan expressed his satisfaction with the results, emphasizing that the company not only met its previous guidance but also simplified its capital structure while significantly improving net leverage.
Continued Growth and Strategic Backlog
In the fourth quarter, Mirion observed organic revenue growth across its Nuclear & Safety and Medical groups, further enhancing adjusted EBITDA margins, which shows the positive momentum continuing into the new year. Logan highlighted that approximately half of the anticipated revenue for 2025 is already secured in the backlog, providing a robust foundation for continued growth.
Potential Large Orders and Market Opportunities
The company is making headway in discussions concerning $300 - $400 million in potential large orders previously disclosed. Mirion sees increased opportunities to engage in bidding for other substantial contracts, demonstrating a proactive approach to market expansion. The favorable trend in the short order-cycle business is also indicative of positive growth in key vertical markets.
Guidance for 2025 and Financial Expectations
Mirion is reaffirming its financial guidance for the fiscal year 2025, projecting revenue growth ranging from 4.0% to 6.0%, alongside adjusted EPS of approximately $0.45 to $0.50 per share, showcasing confidence in its ability to maintain growth trajectories, improve margins, and generate substantial free cash flow.
Detailed 2025 Financial Guidance
• Revenue growth of approximately 4.0% – 6.0%, anticipating a foreign exchange rate headwind of about 190 basis points.
• Organic revenue growth expected at approximately 5.5% – 7.5%, accounting for the impact of the lasers business closure from 2024.
• Projected adjusted EBITDA between $215 million - $230 million, with adjusted EBITDA margins estimated at 24.5% - 25.5%.
• Anticipated adjusted free cash flow ranging from $85 million - $110 million, with an expected conversion rate of 39% - 48% of adjusted EBITDA.
• Adjusted EPS guidance set between $0.45 – $0.50 per share.
Financial Call and Investor Engagement
Mirion plans to hold a conference call to further discuss its financial results and future guidance. Investors and other interested parties are encouraged to participate to gain insights into the company’s strategic direction and operational efficiencies.
About Mirion Technologies
Headquartered in Atlanta, Mirion Technologies, Inc. is at the forefront of providing essential protection and support in radiation safety and detection. With a workforce of approximately 2,800 employees operating across 12 countries, the company is dedicated to advancing health and safety through innovative solutions that leverage ionizing radiation. As a trusted leader, Mirion is committed to empowering advancements in various sectors such as nuclear medicine, occupational dosimetry, and diagnostic imaging.
Frequently Asked Questions
What are the key financial highlights from Mirion's report?
Record revenues, adjusted EBITDA, and adjusted EPS for 2024, with continued guidance for 2025 affirming robust growth.
What is the projected revenue growth for 2025?
Mirion anticipates revenue growth to be between 4.0% and 6.0% for 2025.
How does Mirion's backlog help in future projections?
With about half of its anticipated 2025 revenue already secured in backlog, Mirion has a solid foundation for future revenue.
What markets is Mirion focusing on for growth?
Mirion is particularly focused on medical, nuclear safety, and defense sectors, looking to expand its influence in these areas.
What is the significance of the current guidance from Mirion?
The guidance reflects the company's confidence in sustaining growth, driving margin improvements, and enhancing cash flow generation over the coming years.
